MEDTR vs ADEL Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and ADEL side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | MEDTR | ADEL | Sector median |
|---|---|---|---|
| Last price (TL) | 18.62 | 25.10 | 18.72 |
| Daily change | −4.02% | −5.21% | −4.65% |
| Market cap | TRY 2.2B | TRY 6.5B | TRY 4.4B |
| P/E | 66.43 | — | 18.20 |
| P/B | 0.69 | 5.01 | 1.14 |
| Dividend yield | 0.44% | 1.75% | 0.90% |
| Return on equity | 1.14% | −30.32% | 1.78% |
| Free float | 20.21% | 27.60% | 37.21% |
Popular comparisons
Related pages
About the MEDTR vs ADEL comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and ADEL (Adel Kalemcilik) side by side as of Sep 28, 2026, 11:54. Of the 14 metrics compared, MEDTR leads in 10 and ADEL leads in 4.
Highlights: Daily change: MEDTR leads (−4.02% vs −5.21%). Market cap: ADEL leads (TRY 6.5B vs TRY 2.2B). P/B: MEDTR leads (0.69 vs 5.01). EV/EBITDA: MEDTR leads (7.60 vs 48.26). EV/Sales: MEDTR leads (1.36 vs 5.10). Dividend yield: ADEL leads (1.75% vs 0.44%). Gross margin: ADEL leads (36.40% vs 33.71%). EBITDA margin (annual): ADEL leads (14.03% vs 3.58%).
Frequently asked questions
Is MEDTR or ADEL cheaper?
By P/E, Tie is cheaper (66.43 vs —); by P/B, MEDTR trades at the lower multiple (0.69 vs 5.01).
Which is more profitable, MEDTR or ADEL?
Annual net margin is 1.35% for MEDTR and −15.82% for ADEL; return on equity is 1.14% for MEDTR and −30.32% for ADEL.
Which is more leveraged, MEDTR or ADEL?
The leverage ratio is 15.79 for MEDTR and 71.26 for ADEL; net debt/EBITDA is — for MEDTR and 6.92 for ADEL. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.